Industry Projects - View By Category
Stay up to date with the project updates by clicking on the map or choosing a category from the list below.Projects By Category
Latest Projects - View By Category
Tradjenta - Treatment for Type II Diabetes
Linagliptin (BI-1356), which is being marketed under the trade name Tradjenta, is an orally medicated drug for the treatment of type 2...
Linagliptin (BI-1356), which is being marketed under the trade name Tradjenta, is an orally medicated drug for the treatment of type 2...
Onbrez Capsules - Treatment for Chronic Obstructive Pulmonary Disease
Onbrez capsules are hard capsules developed by Novartis for the treatment of chronic obstructive pulmonary disease (COPD). The capsules are provided with a breezhaler, a device which allows...
Onbrez capsules are hard capsules developed by Novartis for the treatment of chronic obstructive pulmonary disease (COPD). The capsules are provided with a breezhaler, a device which allows...
Nulojix - Treatment for Preventing Acute Organ Rejection Post Kidney Transplantation
Nulojix (Belatacept) was developed by Bristol Myers Squibb and is indicated to prevent the rejection of the organ in patients who have undergone kidney transplantation. The powdered form of...
Nulojix (Belatacept) was developed by Bristol Myers Squibb and is indicated to prevent the rejection of the organ in patients who have undergone kidney transplantation. The powdered form of...
Adcetris - Treatment for Relapsed or Refractory Hodgkin's Lymphoma
Adcetris (Brentuximab) is an investigational drug being developed by Seattle Genetics along with Millenium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical, for the...
Adcetris (Brentuximab) is an investigational drug being developed by Seattle Genetics along with Millenium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical, for the...
Axitinib – Treatment for Advanced Renal Cell Carcinoma
Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular...
Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular...
Corifact – Treatment for Rare Form of Haemophilia
Corifact is an intravenous drug indicated for the treatment of bleeding disorder in patients with factor XIII deficiency. It has been developed and is being manufactured by CSL Behring of...
Corifact is an intravenous drug indicated for the treatment of bleeding disorder in patients with factor XIII deficiency. It has been developed and is being manufactured by CSL Behring of...
Incivek / Telaprevir - Treatment for Chronic Hepatitis C
Incivek (telaprevir) is a protease inhibitor used for treating Hepatitis C infections in liver patients. Vertex Pharmaceuticals is developing the drug in collaboration with the Mitsubishi...
Incivek (telaprevir) is a protease inhibitor used for treating Hepatitis C infections in liver patients. Vertex Pharmaceuticals is developing the drug in collaboration with the Mitsubishi...
Trobalt / Potiga – Treatment for Partial-Onset Seizure
Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged...
Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged...
Xalkori - Treatment for Non-Small Cell Lung Cancer
The FDA approved Xalkori for the treatment of metastatic Anaplastic Lymphoma Kinase (ALK) positive non-small cell lung cancer in August...
The FDA approved Xalkori for the treatment of metastatic Anaplastic Lymphoma Kinase (ALK) positive non-small cell lung cancer in August...
FIRAZYR – Treatment for Hereditary Angioedema
FIRAZYR (Icatibant) is a drug developed and manufactured by Jerini, which was taken over by Shire Pharmaceuticals in 2008. The drug is indicated for the treatment of Hereditary Angioedema...
FIRAZYR (Icatibant) is a drug developed and manufactured by Jerini, which was taken over by Shire Pharmaceuticals in 2008. The drug is indicated for the treatment of Hereditary Angioedema...
